Major Biomedical Research Reagents Supplier Licences Chromatrap ChIP Technology

Product News   Jun 29, 2017 | Original story from Chromatrap

 
Major Biomedical Research Reagents Supplier Licences Chromatrap ChIP Technology
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Lonza Expands Service Offerings for Early Phase Biopharmaceutical Drug Development

Product News

Protein Sequence Variant Analysis de-risks clinical candidates. Site-Specific Conjugation Vectors for GS Xceed® System support expression of second-generation antibody drug conjugates. Developability assessment expanded to include microbial-derived recombinant proteins.

READ MORE

Lonza Launches XS™ Pichia 2.0 Expression and Manufacturing Platform for Development of Next Generation Therapeutics

Product News

New system designed to provide high product titers up to 6 g/L, with a fermentation strategy that results in drastically-reduced fermentation times. Platform is available under license for use in customer’s facility or as a service offering.

READ MORE


Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE